Hikma Pharmaceuticals Market Cap

Hikma Pharmaceuticals has a market cap or net worth of $5.84 billion as of July 11, 2025. Its market cap has increased by 11.51% in one year.

Market Cap

5.84B

Enterprise Value

7.03B

Revenue

3.13B

Ranking

n/a

PE Ratio

16.26

Stock Price

$54.41

Market Cap Chart

Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.84B, an increase of 600.13%. That is a compound annual growth rate of 10.38%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	5.84B	5.52%
Dec 31, 2024	5.53B	9.82%
Dec 29, 2023	5.04B	22.33%
Dec 30, 2022	4.12B	-40.78%
Dec 31, 2021	6.95B	-12.23%
Dec 31, 2020	7.92B	24.01%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.60B
Veradigm	857.64M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	553.58M
Glass House Brands	545.56M
CytoDyn	394.14M
American Oncology Network	343.79M

Market Cap Rankings